Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS) Sees Large Increase in Short Interest

Lotus Pharmaceuticals Inc. (OTCMKTS:LTUS) saw a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 316 shares, an increase of ∞ from the June 15th total of 0 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 3,300 shares, the days-to-cover ratio is presently 0.1 days.

Lotus Pharmaceuticals Price Performance

LTUS stock remained flat at $0.00 during midday trading on Friday. 100 shares of the company’s stock were exchanged, compared to its average volume of 9,232. Lotus Pharmaceuticals has a twelve month low of $0.00 and a twelve month high of $0.01.

Lotus Pharmaceuticals Company Profile

Lotus Pharmaceuticals, trading under the symbol LTUS on the OTC Market, is a Taiwan-based pharmaceutical company specializing in the research, development, manufacturing and marketing of prescription medications. The company’s core operations encompass both the production of a broad range of generic drugs and the advancement of novel compounds aimed at therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases and anti-infective treatments.

Lotus Pharmaceuticals offers multiple dosage forms, including tablets, capsules, injectables and sterile preparations, to meet the needs of hospital and retail pharmacy channels.